Tag:

Sofinnova

Latest Headlines

Latest Headlines

With $25M in the bank, French startup sets its sights on sepsis

France's Inotrem is working up a novel approach to the global scourge of sepsis, and now, thanks to some high-profile investors, the biotech has $25 million to take its immunotherapy from the benchtop to the clinic.

Imperial spearheads $28M round for an upstart in the antibody fragment field

The British biotech has rounded up $28 million (£17.5 million) in first-round venture cash from a group of marquee investors willing to bet big that Crescendo's mouse platform can deliver the best in cutting-edge antibody fragment therapeutics.

Swiss biotech raises $50.6M to further hearing-loss drugs

Swiss biotech Auris Medical has raised $50.6 million in a series C round of financing to advance its two major therapeutics for the treatment of inner ear disorders.

Sofinnova reaps $312M for its dedicated life sciences fund

Bucking weak investor interest in the life sciences, Paris-based Sofinnova--a longtime player in biotech venture circles--has put together a $312 million fund that will be entirely dedicated to the life sciences.

New $317M biotech fund takes off at Wellcome Trust

The U.K's wealthiest charity has blueprinted big plans to back fledgling therapeutics and diagnostics companies with a brand new £200 million ($317 million) fund.

VC dollars flowing into Europe

Europe may becoming a major draw for venture capital, Xconomy reports.